Arcus Biosciences, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $1.4M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $47.2M |
| SG&A Expense | $7.6M |
| Operating Income | $-53.4M |
| Operating Margin | -3,782.1% |
| Interest Expense | — |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-53.1M |
| Net Margin | -3,756.7% |
| EPS (Basic) | $-3.23 |
| EPS (Diluted) | $-3.23 |
| Shares Outstanding (Basic) | 35.0M |
| Shares Outstanding (Diluted) | 35.0M |
| Dividends Per Share | — |